The broad conference program addresses many aspects of hemophilia management including identifying current unmet needs, reviewing the new advances in hemophilia treatment (Session 2: Design and Technology), addressing the observations and outcomes of clinical practice and registries, and also discussing how to increase protection - what that means now and in the future.

In addition to the traditional plenary sessions, the Conference delegates will breakout into Workshops for Session 4: Testing and Measurement, where they will learn in small interactive groups from experts in pharmacokinetics and assays. There will also be a Hemophilia Slam session; a platform for invited researchers in the field of hemophilia to deliver short, focused presentations on their latest data and research. The Poster Viewing Session on Friday afternoon provides participants with an opportunity to meet with the Slam presenters and engage with them in discussion on their research.